[Remote] (Senior) Medical Science Liaison - New York at Tempus

New York, New York, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, OncologyIndustries

Requirements

Fundamental understanding of the field of molecular oncology, comprehensive genomic profiling, tumor evolution, and relevant targeted therapy options in early and advanced stage cancer, with ability to interpret clinical trial data
Existing KOL relationships in the field of oncology
Working knowledge of genomic laboratory-developed testing (LDT) with tissue and liquid biopsy; familiarity with CLIA-88’, CAP, Sunshine Act (2013)
Proficient public speaking skills with an ability to effectively communicate clinical data and complex scientific concepts
Exceptional interpersonal communication skills, strong inter- and intradepartmental management skills, ability to educate and train
Self-starter, who can work autonomously to deliver on tight timelines
Ability to travel (50%)
Advanced scientific or medical degree (PhD, PharmD, MD, MSN, BSN)
Basic understanding of oncology required; basic understanding of molecular testing strongly preferred
Residing in NY/CT/NJ, with 50% travel throughout NY, concentration in NYC
Preferred: 1+ years of MSL experience in diagnostics, biotech or pharmaceutical industries

Responsibilities

Serve as a subject matter expert supporting commercial team efforts with deep and current understanding of the oncology landscape, including diagnostic tests, disease states, treatment paradigms, and emerging biomarkers and technologies
Build relationships with Key Opinion Leaders (KOLs) and other HCP experts, including oncologists, pathologists, lab directors, and researchers
Deliver scientific presentations and promote exchange of clinical/scientific/technical information with regional KOLs, community physicians, medical directors, and other HCPs in the field of oncology regarding Tempus oncology products. This will include proactive and reactive communication of scientific data
Facilitate discussions for insights in clinical research, unmet needs, and emerging trends in testing practices
Provide scientific education for internal stakeholders in collaboration with Learning & Development team
Continuously update internal stakeholders on relevant medical and scientific insights as well as proactively sharing market intelligence

Skills

Key technologies and capabilities for this role

OncologyGenomic TestingPrecision MedicineKOL ManagementScientific PresentationsBiomarkersClinical ResearchPhysician EducationEmerging Technologies

Questions & Answers

Common questions about this position

What is the location and travel requirement for this MSL role?

The role is field-based for candidates residing in NY/CT/NJ, with 50% travel throughout NY, concentrated in NYC.

What salary or compensation is offered for this position?

This information is not specified in the job description.

What key skills are required for the Senior Medical Science Liaison role?

Candidates need a fundamental understanding of molecular oncology, comprehensive genomic profiling, and targeted therapies; existing KOL relationships in oncology; working knowledge of genomic LDTs with tissue and liquid biopsy; proficient public speaking; and exceptional interpersonal communication skills.

What does Tempus value in its company culture for this role?

Tempus seeks high-performing, self-starting individuals passionate about precision medicine, with a focus on advancing healthcare through AI-driven insights, building KOL relationships, and collaborating across teams.

What makes a strong candidate for this MSL position at Tempus?

A strong candidate has a strong clinical and scientific background in oncology and genomic testing, existing KOL relationships, and excellent communication skills to educate HCPs, along with the ability to travel 50%.

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free